Introduction

40
In the midst of worldwide obesity and diabetes epidemics, it is crucial to find new avenues to 41 gain insight into the pathophysiology and treatment of these disorders. Brown adipose tissue
42
(BAT) is of particular interest since in addition to its role in adaptive thermogenesis, it may also 43 protect against weight gain, insulin resistance/ diabetes and metabolic syndrome (1-3). Indeed, 44 because of its very high metabolic activity, very little functional BAT can have a profound 45 metabolic impact (4, 5).
46
Studies using PET/CT scanning have shown metabolically active BAT in adult humans 47 whose activity correlated inversely with body fat (5, 7, 8). Significant amounts of functional 48 BAT have been detected in more than 95% of lean subjects in response to acute and chronic cold 49 exposure in controlled prospective studies (5, 8, 9, 10). Since BAT activity is induced by cold 50 exposure, BAT might play an important role in human thermogenesis and energy balance. This 51 is in accordance with studies in small rodents, which showed that cold-exposure stimulates BAT 52 activity by increasing sympathetic nerve activity and by affecting local thyroid hormone (TH) 53 metabolism (11, 12). Cold exposure increases the expression and activity of tissue deiodinase 2 54 (DIO2), which stimulates the conversion of thyroxine (T4) to active triiodothyronine (T3), 55 resulting in increased local T3 production from T4 and TH receptor saturation (13). Both Thus, TH has been shown to have an important role in cold adaptation in rodents, and it may be 63 important for temperature adaptation in humans (18). Understanding cold adaptation in adult 64 humans is important, since factors that increase energy dissipation through facultative thermogenesis could potentially be used as anti-obesity agents (18, 19) . If TH can influence
66
BAT mass and activity and through this energy expenditure, then TH or its analogues might be 67 useful in the treatment of obesity and the metabolic syndrome. to measure BAT mass and activity, first while profoundly hypothyroid at the time of the RAI 78 treatment and then three to six months after starting TH suppressive treatment when they were 79 thyrotoxic. We compared the BAT mass and activity measured on these two scans. We also 80 evaluated the relationship between BAT, TH status, and calorimetric and metabolic parameters. corticosteroids or other medications known to cause insulin resistance in the previous 6 weeks.
Materials and Methods
82
Study Participants
91
Patients with a history of any local or systemic infectious disease with fever or requiring 92 antibiotic within four weeks of the PET/CT scans were not enrolled in the study.
93
Study Protocol (Figure 1) 
94
The patients participated in a short screening visit to evaluate eligibility prior to the RAI 95 treatment followed by two longer study visits when the whole-body BAT volume and activity
96
were measured by 18F-FDG PET/CT under cold stimulation at 15-16°C, first in the hypothyroid 97 state at the time of the RAI treatment and then in the thyrotoxic state 3-6 months after starting 98 TH suppressive treatment. Six out of the eight patients who started the study completed all study 99 visits and were included in the analysis. Prior to participating in the study, one patient 100 underwent completion thyroidectomy for a thyroid nodule positive for papillary thyroid 101 carcinoma on fine needle aspiration cytology, while five patients underwent hemithyroidectomy The patients were prepared for the study visits as previously described (24, 25). Baseline 
121
To maximize the BAT activity/FDG uptake and PET-CT scan BAT visualization, the right lobe of the liver and skeletal muscle (erector spinae) was also measured.
Physiological and Laboratory Parameters
149
Blood pressure and heart rate were measured using a SureSigns VS3 vital signs monitor 
Statistical Analysis
161
This pilot study was designed to evaluate whether the TH status had an effect on BAT mass 162 and activity in adult humans, specifically whether treatment with TH increases BAT mass and 163 activity as the subjects transitioned from hypothyroidism to thyrotoxicosis. We anticipated 164 consenting and screening up to 10 patients, so that 6-8 patients would complete all segments of 165 the study (completion rate of 80%).
166
Data were analyzed using Statistical Package for the Social Science (SPSS, IBM, Armonk,
167
New York) and Statistical Analysis System (SAS, SAS Institute, Inc.). All P values presented 168 are two-tailed, and values ≤ 0.05 were considered to indicate statistical significance, while values 169 < 0.10 were considered to represent a trend to achieve significance. Changes in BAT volume, activity and maximum standardized uptake value (SUVmax), as well as hormonal and metabolic 171 changes in the study patients between the hypothyroid and thyrotoxic state were evaluated using 172 the non-parametric Wilcoxon signed-rank test. Associations between BAT volume and activity,
173
TH and metabolic parameters were evaluated by Spearman correlation.
174
Results
175
The baseline characteristics of the six patients who completed the study are summarized in 176   Table 1 . Five patients had a normal baseline TSH prior to being enrolled in the study. One 177 patient who was enrolled at the time of her completion thyroidectomy, had a low baseline TSH 178 of 0.19 (reference range 0.27-4.2 µIU/mL) on TH treatment prior to starting the study. All 179 patients were hypothyroid after TH withdrawal at the time of the first study PET/CT scan. In 4 180 out of the 6 study patients, the final TSH was in the thyrotoxic range, while the fifth patient had a 181 TSH in the low reference range at 0.38 µIU/mL 3-6 months after starting TH suppressive 182 treatment at the time of the second PET/CT scan. However, the sixth patient had a final TSH of 183 5.46 µIU/mL. Therefore, although the mean was in the euthyroid range, all patients but one were 184 thyrotoxic at the time of the second PET/CT scan.
185
Thyroid function tests and metabolic parameters. TSH was higher while total T4, free T4 186 index, free T3 and T3 uptake were lower in the hypothyroid compared to the thyrotoxic state (Table 2) .
207
There was a positive correlation between the RQ measured at room temperature and after 60 min 
217
The majority but not all (4 out of 6) patients showed an increase in detectable, acute, cold- 
227
There was a negative correlation between the cold-induced BAT volume as well as activity 228 and the subjects' weight and BMI in both the hypothyroid and thyrotoxic state. There was no 229 correlation between the BAT parameters and the subjects' age and core body temperature. The It is important to consider that all study patients showed detectable cold-activated BAT in the 272 hypothyroid state, even at TSH levels higher than 100 µIU/mL, which indicates that even low 273 levels of TH are adequate for BAT activation in adult humans. In our study, serum T3 levels BAT are complex and one of these mechanisms may be predominant, which could explain the 295 different BAT responses to cold exposure noted in different patients.
296
We did not find a correlation between the change in thyroid function or the change in RMR 297 and the change in cold-induced BAT volume and activity between the hypothyroid and 298 thyrotoxic state. This may be explained by the fact that TH influences both the basal/obligatory 299 and facultative thermogenesis through different mechanisms (11, 29). A treatment that would 300 selectively stimulate facultative thermogenesis could be beneficial for weight loss and 301 improvement in metabolic parameters without the side effects of elevated circulating TH levels.
Our study showed that circulating T3 is a stronger predictor of the change in energy 303 expenditure compared to cold-induced BAT activity. However, the response to TH treatment led 304 to opposite responses among two of the principal thermogenic organs: glucose uptake in the 305 liver was lower, but skeletal muscle uptake was higher. Therefore, it cannot be assumed that all 306 tissues respond the same to chronic treatment with TH. Our findings also support the hypothesis 307 that TH contributes significantly to cold-induced thermogenesis by affecting multiple organs 308 including skeletal muscle in addition to BAT (30, 31, 21, 22). In our study, there was a more 309 consistent increase in the skeletal muscle activity as compared to the BAT activity between the 310 hypothyroid and thyrotoxic state. This may be explained by the fact that the skeletal muscle 311 activity is mainly regulated by thyroid hormone, while the synergistic activity with the SNS may 312 be less important in this tissue (32). In addition, the difference between the two tissues could be 313 potentially explained by the fact that our study patients took high-dose levothyroxine at the time 314 of the second PET-CT scan, which can decrease DIO2 activity; this enzyme has more important 315 effects in BAT than skeletal muscle (33).
316
The few published human studies looking at the relationship between thyroid status and BAT 
333
We recruited thyroid cancer patients for this pilot study. This represents an excellent study 334 model for BAT evaluation since treatment for thyroid cancer involves several steps including 
339
This is a pilot study designed with the goal to obtain preliminary data in a small but 340 physiologically informative group of patients with thyroid cancer whose clinical course involves 341 treatment with high-dose levothyroxine to change their thyroid status from severe 342 hypothyroidism to mild thyrotoxicosis. The signal from this cohort would be a best-case 343 scenario for any studies in healthy subjects or patients with milder hypothyroidism. Our data show that based on the mean change in BAT metabolic activity, we would have to study more 345 than a total of 50 pairs of subjects to demonstrate a significant effect of thyroid hormone 346 treatment on detectable BAT. Therefore, this pilot study has achieved one of its essential goals 347 and demonstrated that is not very feasible to use levothyroxine treatment in most populations as 348 a way of increasing BAT mass or metabolic activity.
349
As known from prior animal as well as human studies, chronic cold exposure is probably the 350 strongest determinant of BAT volume and activity (9,10). Based on our study design, we cannot confounded the modest effect we saw from chronic exposure to high doses of thyroid hormone.
355
In our study, we measured cold-induced BAT, since significant amounts of functional BAT have 356 been detected in more than 95% of lean subjects in response to acute cold exposure (5, 8), while 357 significantly fewer subjects showed detectable BAT via PET-CT scanning when studied at room 358 temperature. With the current study design we were able to evaluate the effect of TH on cold-359 induced BAT by studying the same patients after cold exposure in both the hypothyroid and 360 thyrotoxic state. Therefore, we can infer that the change in the BAT mass and activity between 361 the two phases is related to the thyroid hormone status change.
362
In conclusion, in this pilot study we found that all 6 study patients had detectable BAT after 2 363 hours of cold exposure in both the hypothyroid and thyrotoxic state, and the majority but not all 
